Top Markets
#1 Siacoin Siacoin +18.72%
#2 Cash Cat Cash Cat +12.00%
#3 Seeker Seeker +10.47%
#4 DogBull DogBull +9.87%
#5 0G 0G +7.70%
#6 Story Story +5.49%
#7 The Black Bull The Black Bull +5.17%
#8 Useless Coin Useless Coin +5.06%
#9 The Bitcoin Bull The Bitcoin Bull +4.99%
#10 Linea Linea +4.75%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rank in Stocks #14294
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Share Price
$17.15
Last synced: 2026-08-31
Market Cap
$423.01M
Change (1 day)
4.67%
Change (1 year)
112.68%
Country
IN
Trade Novartis India Limited (NOVARTIND)

Category

Healthcare
Revenue for Novartis India Limited (NOVARTIND)
Revenue in Sep 2026 TTM: 0
According to Novartis India Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novartis India Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH